Gorsky R D, Pamuk E, Williamson D F, Shaffer P A, Koplan J P
Department of Health Management and Policy, University of New Hampshire, USA.
Am J Prev Med. 1996 Sep-Oct;12(5):388-94.
Previously published reports strongly suggest that being overweight is a risk factor for coronary heart disease, hypertension, diabetes, gallstones, and osteoarthritis in women. Substantial health care and medication costs are associated with these chronic health conditions. We used an incidence-based analysis to estimate the excess costs associated with women maintaining an overweight status during the 25-year period from age 40 to 65 years.
The health care costs of three hypothetical cohorts of 10,000 40-year-old women were extrapolated to age 65. The non-overweight cohort maintained a body mass index (BMI; weight [kg]/height [m2]) of 21 to 24.9; the moderately overweight cohort maintained a BMI of 25 to 28.9; the severely overweight cohort maintained a BMI of > or = 29. The number of fatal and nonfatal health outcomes in each cohort for heart disease, hypertension, diabetes mellitus, gallstones, and osteoarthritis was calculated with their associated costs.
We estimated that when compared with the non-overweight cohort of 10,000 women, the cohort of 10,000 women who had a BMI of > or = 29 incurred excess costs of $53 million over a 25 year period (discounted at 3% per year) and 497 excess deaths. The cohort of 10,000 women who had a BMI of 25-28.9 incurred excess costs of $22 million (discounted at 3% per year) and 212 excess deaths, compared with the non-overweight cohort.
The results of this study indicate that an estimated $16 billion will be spent during the next 25 years treating health outcomes associated with overweight in middle-aged women in the United States. Thus, a substantial health burden is associated with the increasing prevalence of overweight women in the United States. Preventing excess coronary heart disease, gall-stones, osteoarthritis, hypertension, and diabetes through prevention of weight gain, particularly among reproductive-aged women, may be a cost-effective strategy.
先前发表的报告有力地表明,超重是女性患冠心病、高血压、糖尿病、胆结石和骨关节炎的危险因素。这些慢性健康状况会带来大量的医疗保健和药物成本。我们采用基于发病率的分析方法,来估算40岁至65岁的女性在25年期间维持超重状态所产生的额外成本。
将三组各10,000名40岁女性的医疗保健成本推算至65岁。非超重组的体重指数(BMI;体重[千克]/身高[米²])维持在21至24.9之间;中度超重组的BMI维持在25至28.9之间;重度超重组的BMI维持在29及以上。计算每组中因心脏病、高血压、糖尿病、胆结石和骨关节炎导致的致命和非致命健康结局数量及其相关成本。
我们估计,与10,000名非超重女性组相比,BMI在29及以上的10,000名女性组在25年期间(按每年3%贴现)产生了5300万美元的额外成本和497例额外死亡。与非超重组相比,BMI在25 - 28.9之间的10,000名女性组产生了2200万美元的额外成本(按每年3%贴现)和21例额外死亡。
本研究结果表明,未来25年美国用于治疗中年超重女性相关健康结局的费用预计将达160亿美元。因此,美国超重女性患病率的上升带来了沉重的健康负担。通过预防体重增加,尤其是在育龄女性中预防体重增加,以预防额外的冠心病、胆结石、骨关节炎、高血压和糖尿病,可能是一种具有成本效益的策略。